Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Metastases × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 10 Breast Neoplasms 8 Multiple Myeloma 7 Pain 4 Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Pleural Effusion, Malignant 1 Osteonecrosis 1 Osteolysis 1 Lung Neoplasms 1 Lung Metastases 1 Carcinoma, Renal Cell 1

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡